Simplex Trading
CRBP icon

Simplex Trading’s Corbus Pharmaceuticals CRBP Stock Holding History

Simplex Trading’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$860K Buy
+91,600
New +$771K ﹤0.01% 2663
2025
Q4 		– Sell
-11,000
Closed -$139K – 8772
2025
Q3 		$139K Buy
11,000
+10,800
+5,400% +$103K ﹤0.01% 5379
2025
Q2 		$1K Hold
200
– – ﹤0.01% 8284
2025
Q1 		$1K Sell
200
-5,200
-96% -$45.9K ﹤0.01% 8176
2024
Q4 		$63K Sell
5,400
-52,700
-91% -$884K ﹤0.01% 5626
2024
Q3 		$1.2M Buy
58,100
+55,900
+2,541% +$2.86M ﹤0.01% 2759
2024
Q2 		$99K Buy
2,200
+1,600
+267% +$67.3K ﹤0.01% 5382
2024
Q1 		$23K Buy
+600
New +$14.8K ﹤0.01% 6977
2023
Q1 		– Sell
-3,870
Closed -$12K – 9159
2022
Q4 		$12K Sell
3,870
-80
-2% -$308 ﹤0.01% 7351
2022
Q3 		$19K Sell
3,950
-307
-7% -$2.17K ﹤0.01% 7565
2022
Q2 		$32K Sell
4,257
-200
-4% -$1.93K ﹤0.01% 7048
2022
Q1 		$71K Buy
4,457
+1,687
+61% +$22.4K ﹤0.01% 6631
2021
Q4 		$51K Buy
2,770
+780
+39% +$21.1K ﹤0.01% 7234
2021
Q3 		$108K Buy
1,990
+10
+0.5% +$394 ﹤0.01% 6512
2021
Q2 		$108K Buy
1,980
+1,941
+4,977% +$108K ﹤0.01% 6617
2021
Q1 		$228K Buy
39
+12
+44% +$789 ﹤0.01% 4554
2020
Q4 		$102K Sell
27
-58
-68% -$2.17K ﹤0.01% 5426
2020
Q3 		$460K Buy
85
+65
+325% +$11.8K ﹤0.01% 3106
2020
Q2 		$513K Sell
20
-14
-41% -$2.83K ﹤0.01% 2874
2020
Q1 		$533K Buy
34
+19
+127% +$3.21K ﹤0.01% 2520
2019
Q4 		$243K Buy
15
+13
+650% +$1.92K ﹤0.01% 3543
2019
Q3 		$27K Sell
2
-1
-33% -$174 ﹤0.01% 5566
2019
Q2 		$59K Sell
3
-1
-25% -$214 ﹤0.01% 4713
2019
Q1 		$79K Buy
4
+2
+100% +$441 ﹤0.01% 4591
2018
Q4 		$29K Buy
+2
New +$399 ﹤0.01% 5017
2018
Q3 		– Sell
-1
Closed -$12K – 7476
2018
Q2 		$12K Sell
1
-2
-67% -$363 ﹤0.01% 6213
2018
Q1 		$1K Buy
+3
New +$674 ﹤0.01% 5572
2017
Q4 		– Sell
-6
Closed -$10K – 6067
2017
Q3 		$10K Sell
6
-3
-33% -$587 ﹤0.01% 3756
2017
Q2 		$1K Sell
9
-10
-53% -$1.96K ﹤0.01% 5555
2017
Q1 		$19K Buy
19
+10
+111% +$2.45K ﹤0.01% 3290
2016
Q4 		$32K Buy
+9
New +$2.06K ﹤0.01% 2593

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
DP
Diadema Partners Morristown, New Jersey $588M AUM 182.75% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Simplex Trading's CRBP Position: Q1 2026 in Review

Simplex Trading opened a new position in Corbus Pharmaceuticals (CRBP) in Q1 2026: 52,836 shares worth $496K. The stake represents ﹤0.01% of the portfolio and ranks #3272 among its holdings. This is a return to the name: Simplex Trading previously reported a position in CRBP as recently as Q3 2025.

Simplex Trading first reported a position in CRBP in Q3 2016 and has held it in 23 quarters since. The position peaked at $794K in Q2 2020. 107 funds tracked by Wall St. Rank hold CRBP as of Q1 2026.

  • Simplex Trading held 52,836 shares of Corbus Pharmaceuticals worth $496K as of Q1 2026.
  • Corbus Pharmaceuticals was a new Simplex Trading position in Q1 2026.
  • Corbus Pharmaceuticals made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #3272 holding.
  • Simplex Trading first reported a position in Corbus Pharmaceuticals in Q3 2016 and has held it in 23 quarters since.
  • Simplex Trading's Corbus Pharmaceuticals position peaked at $794K in Q2 2020.
  • 107 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.